Source: International Congress 2017 – COPD biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Chen (Chengdu, China). Elevated BALF PEDF levels are related to disease severity, inflammation and small airway obstruction in COPD patientes. 3604

Member's Comments

No comment yet.

Related content which might interest you: COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Airway neutrophilia in chronic airways disease (CAD) is associated with lower lung function and reduced soluble(s)RAGE Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Airway neutrophilia in COPD is not associated with increased neutrophil survival Source: Eur Respir J 2006; 28: 1163-1169 Year: 2006 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Airway pathology in asthma Source: Eur Respir J 2001; 18: 18S-23S Year: 2001 The expression of MMP2, 9 and TIMP1 mRNA in bronchoalveolar cells of patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009